NEW YORK, April 13, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of FibroGen, Inc. (NASDAQ: FGEN) between November 8, 2019 and April 6, 2021, inclusive (the "Class...
from PR Newswire: https://ift.tt/3abQ9SO
No comments:
Post a Comment